Acción XAIR BEYOND AIR, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Beyond Air, Inc.

Acciones

XAIR

US08862L1035

Tiempo real estimado Cboe BZX
Otros sitios de cotización
 16:34:34 26/06/2024 		Varia. Cinco días. Varia. 1 de enero.
0,621 USD -4,36 % Gráfico intradía de Beyond Air, Inc. -51,91 % -67,86 %
25/06 Actualización del sector: Los valores del sector sanitario ceden a última hora de la tarde MT
25/06 Actualización del sector: Atención sanitaria MT

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!
Inscripción 100% Gratuita
Sector Update: Health Care Stocks Ease Late Afternoon
Sector Update: Health Care
Top Midday Decliners
Beyond Air Share Plunge After Fiscal Q4 Loss Exceeds Estimates
Beyond Air, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024
Beyond Air : Corporate Presentation
Beyond Air® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Beyond Air, Inc. Updates Revenue Guidance for the Fiscal Year 2025
Certain Wwarrants of Beyond Air, Inc. are subject to a Lock-Up Agreement Ending on 20-JUN-2024.
Certain Restricted Stock Units of Beyond Air, Inc. are subject to a Lock-Up Agreement Ending on 20-JUN-2024.
Certain Stock Options of Beyond Air, Inc. are subject to a Lock-Up Agreement Ending on 20-JUN-2024.
Certain Common Stock of Beyond Air, Inc. are subject to a Lock-Up Agreement Ending on 20-JUN-2024.
Beyond Air Names Chief Commercial Officer
Beyond Air® Appoints David Webster as Chief Commercial Officer
Beyond Air Appoints David Webster as Chief Commercial Officer, Effective from July 8, 2024
Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO)
Beyond Air : Corporate Presentation
Beyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast
Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting
Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción XAIR
  4. Noticias Beyond Air, Inc.
  5. Otros idiomas